ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A…

Overview of attention for article published in Trials, July 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 16,929 followers.

RT @LeakusMaximus: @o_rips Did they use a US company called IQVIA to find ideal candidates? That got the ACCORD-2 contract. The same compan…

RT @LeakusMaximus: @o_rips Did they use a US company called IQVIA to find ideal candidates? That got the ACCORD-2 contract. The same compan…

RT @LeakusMaximus: @o_rips Did they use a US company called IQVIA to find ideal candidates? That got the ACCORD-2 contract. The same compan…

@o_rips Did they use a US company called IQVIA to find ideal candidates? That got the ACCORD-2 contract. The same company that ran the ONS' £740m UK covid survey? https://t.co/BA7sojQOcd https://t.co/KNOxrZxJrB